Voyageur Pharmaceuticals Ltd VYYRF

Primary Symbol: V.VM

Healthcare Drug Manufacturers - Specialty & Generic

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.

TSXV:VM - Post by User

Voyageur Pharmaceuticals Ltd > Nothing holding Voyageur back to new 2024 lows

<< Previous

Bullboard Posts

Next >>

Comment by oldtroufon Apr 11, 2024 2:17pm

110 Views

Post# 35983869

RE:Nothing holding Voyageur back to new 2024 lows

VM will go to one penny soon. There are NO BIDS. Seem like a shell company. Not 1 news release in the past FOUR years has produced any results. Pie in the sky penny stock with zero credibility. Chapter 11 will come very quickly without sales os some sort. One percent chance this does not go to zero.

<< Previous

Bullboard Posts

Next >>

Investors eye Australian gold mining projects amid promising developments